All Blog Posts

What are the biggest challenges for researchers and scientists today? Where do they find the best resources for the work? How do they go along with social media? We got interesting feedback from our colleagues, researchers, and scientists answering our polls on social media. We want to share them with you in this story and add some global biotech industry trends.

In our new ”Interview with a Scientist” blog post, we asked Antonio Marzio, Ph.D., about his research on the mechanisms that drive immune-resistant responses in patients with non-small-cell lung carcinoma (NSCLC). Read on to learn more!

Primary antibodies are a powerful tool in basic research. In our new research roundup dedicated to neuroscience, we talk about a mechanism responsible for drug resistance in epileptic patients and a newly discovered and evolutionarily conserved feature of oligodendrocytes.

March 8th is international women’s day, celebrated globally. The day is about honoring female achievements and raising awareness for the gender inequalities women face all over the world. Hear from two female managers at Atlas Antibodies about their own experiences, and what advice they would give to young women.

In our employee spotlight series, we share the story of the people behind Atlas Antibodies. To keep up with our series it is now time to meet the next person, Marie Utterbäck. She has been with the company for seven years and currently works as a product manager. During her voyage she has transitioned from starting out in research and development, to gradually move towards a more commercial role. Keep reading to take part in her exciting journey, and to learn more about the opportunities that lie within a company in growth.

Antibody-based immunoassays are widely used in exploratory preclinical and pharmaceutical research as tools for discovering new druggable protein targets. Read about the 10 ways to explore and map the human proteome and how it helps researchers and clinicians on their discovery journeys.

Twenty new blog posts, interviews with prominent scientists, employee spotlights, research highlights, acquisitions and collaborations, certification, product launches, and a new CEO. What a year for Atlas Antibodies! Read all about it.

The classification of gliomas is changing profoundly, shifting from a morphology-based guide to a system based on molecular criteria, built around their genomic landscape and data from next-generation sequencing. Read more to learn about the key molecular markers that allow the latest classification of gliomas.

Our new Research Roundup summarises three cancer research studies that have used polyclonal antibodies from Atlas Antibodies. Today we share insights into a new biomarker for glioma, the metastatic process in colorectal cancer, and the effect of ginseng metabolites on cancer cells proliferation. Learn more!

T-Cell receptors therapy is a growing area of immuno-oncology with recent breakthroughs in clinical settings, thereby demonstrating his therapeutic potential in mitigating tumor development. So what do you know about T-Cell therapy? Read on! Dr. Erika von Euw from T-Cure Bioscience help us to understand it better.